Adherence to BNF Prescribing Standards and PRN Governance in an Early Intervention in Psychosis Service: TwoCycle Clinical Audit
BJPsych Open · 2026-06 · 12 (S1) · S280-S280
DOI: 10.1192/bjo.2026.11653 ↗At a glance
Journal article in BJPsych Open, published online on 2026-06-30. Written by Sita Asi and 4 co-authors. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Aims
(1) Quantify adherence to British National Formulary (BNF) dose limits; (2) Measure polypharmacy prevalence and rationale documentation; (3) Assess as required (PRN) governance (instruction clarity, review frequency, benzodiazepine duration); and (4) Compare high-dose antipsychotic therapy (HDAT) form completion between cycles.
Methods
Retrospective analysis of electronic health records (EHR) exported to standardised spreadsheets. Polypharmacy defined as being more than 2 medications of the same class. Doses were expressed as %BNF maximum across six medication classes: >100% denoted high-dose prescribing. PRN indicators captured instruction presence, review status, and benzodiazepine duration ≤4 weeks. Analyses were performed programmatically on two audit cycles.
Results
BNF adherence worsened: patients exceeding BNF maxima decreased from 1% (Cycle 1) to 2.9% (Cycle 2). Polypharmacy increased from 5.6% to 10.4% ; (e.g., switching medications/complex illness/patient preference) likely contributed, but the rise suggests persistent clinical complexity. PRN governance was mixed: “PRN not reviewed” improved from 1.9% to 1.45% , while “PRN instruction missing” rose from 1.1% to 2.1% . Benzodiazepine PRN >4 weeks increased from 0.26% to 2.70% , indicating a stewardship gap. HDAT documentation remained suboptimal but improved: 1/378 (0.002%) forms completed in Cycle 1 vs 3/482 (0.62%) in Cycle 2.
Conclusion
The re-audit demonstrates worsening of BNF dose exceedance and a modest improvement in PRN review , evidencing strengthened prescribing safety processes. Nevertheless, polypharmacy increased, and benzodiazepine PRN durations lengthened, while HDAT form completion remains low. Priorities are: (i) embedding EHR “hard-stops” for >100% BNF doses and missing PRN instructions; (ii) automated four-week PRN benzodiazepine review prompts with default taper plans; (iii) a structured polypharmacy pro-forma recording indication, expected benefit, and review date; and (iv) targeted HDAT training plus mandatory electronic prompts for form completion. A third-cycle re-audit using identical denominators is recommended to verify sustained improvement and close remaining governance gaps
Cite
APA
Asi, S., Sabtan, Y., Chakraborty, N., Ahmed, M., & Elamien, D. (2026). Adherence to BNF Prescribing Standards and PRN Governance in an Early Intervention in Psychosis Service: TwoCycle Clinical Audit. BJPsych Open, 12(S1), S280-S280. https://doi.org/10.1192/bjo.2026.11653
Vancouver
Asi S, Sabtan Y, Chakraborty N, Ahmed M, Elamien D. Adherence to BNF Prescribing Standards and PRN Governance in an Early Intervention in Psychosis Service: TwoCycle Clinical Audit. BJPsych Open. 2026;12(S1):S280-S280. doi:10.1192/bjo.2026.11653
BibTeX
@article{Asi2026,
author = {Asi, Sita and Sabtan, Yassmine and Chakraborty, Nandini and Ahmed, Muhammad and Elamien, Dina},
title = {Adherence to BNF Prescribing Standards and PRN Governance in an Early Intervention in Psychosis Service: TwoCycle Clinical Audit},
journal = {BJPsych Open},
year = {2026},
volume = {12},
number = {S1},
pages = {S280--S280},
doi = {10.1192/bjo.2026.11653}
}
EUVIMED